Soleno Therapeutics (SLNO) EBIT (2013 - 2026)
Soleno Therapeutics (SLNO) reported EBIT of $31.3 million for Q1 2026, up 168.38% year-over-year from $11.7 million in Q1 2025, and down 20.97% quarter-over-quarter from $39.6 million in Q4 2025.
Soleno Therapeutics (SLNO) EBIT (2013 - 2026) Analysis & Trends
Soleno Therapeutics (SLNO) has 14 years of EBIT data on file, last reported at $31.3 million in Q1 2026.
- EBIT for Q1 2026 came in at $31.3 million, up 168.38% year-over-year; the trailing twelve-month figure through Mar 2026 was $86.4 million (up 141.17% YoY), and the FY2025 annual result was $9.4 million, up 105.02% from the prior year.
- EBIT declined to $31.3 million in Q1 2026 per SLNO's latest filing, from $39.6 million in the prior quarter.
- Over five years, EBIT peaked at $39.6 million in Q4 2025 and troughed at -$80.2 million in Q3 2024.
- A 5-year average of -$12.5 million and a median of -$8.5 million in 2023 frame the typical range for EBIT.
- The sharpest annual moves came in 2024 and 2026: EBIT tumbled 672.61% in 2024, then jumped 168.38% in 2026.
- A 5-year view of EBIT shows it stood at -$5.6 million in 2022, then sank by 147.95% to -$13.9 million in 2023, then tumbled by 324.99% to -$59.1 million in 2024, then surged by 166.95% to $39.6 million in 2025, then retreated by 20.97% to $31.3 million in 2026.
- Business Quant data shows SLNO's EBIT at $31.3 million in Q1 2026, $39.6 million in Q4 2025, and $22.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -32.68 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.82 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -15.76 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.51 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -65.83 Mn |
| 10 | Soleno Therapeutics | 2.76 Bn | 2.51 Bn | 93.41 Mn | 31.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 31.28 Mn |
| Dec 31, 2025 | 39.58 Mn |
| Sep 30, 2025 | 22.11 Mn |
| Jun 30, 2025 | -6.53 Mn |
| Mar 31, 2025 | -45.74 Mn |
| Dec 31, 2024 | -59.12 Mn |
| Sep 30, 2024 | -80.21 Mn |
| Jun 30, 2024 | -24.87 Mn |
| Mar 31, 2024 | -23.48 Mn |
| Dec 31, 2023 | -13.91 Mn |
| Sep 30, 2023 | -10.38 Mn |
| Jun 30, 2023 | -8.62 Mn |
| Mar 31, 2023 | -8.47 Mn |
| Dec 31, 2022 | -5.61 Mn |
| Sep 30, 2022 | -6.24 Mn |
| Jun 30, 2022 | -6.78 Mn |
| Mar 31, 2022 | -5.77 Mn |
| Dec 31, 2021 | -3.00 Mn |
| Sep 30, 2021 | -8.29 Mn |
| Jun 30, 2021 | -11.09 Mn |